Frazier Management as of June 30, 2021
Portfolio Holdings for Frazier Management
Frazier Management holds 34 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arcutis Biotherapeutics (ARQT) | 21.2 | $230M | 8.4M | 27.29 | |
| Phathom Pharmaceuticals (PHAT) | 18.2 | $197M | 5.8M | 33.85 | |
| Passage Bio (PASG) | 6.1 | $66M | 5.0M | 13.24 | |
| Mirum Pharmaceuticals (MIRM) | 5.7 | $62M | 3.6M | 17.29 | |
| Translate Bio | 5.3 | $57M | 2.1M | 27.54 | |
| Iovance Biotherapeutics (IOVA) | 5.1 | $56M | 2.1M | 26.02 | |
| Krystal Biotech (KRYS) | 4.9 | $54M | 788k | 68.00 | |
| Vaxcyte (PCVX) | 4.8 | $52M | 2.3M | 22.51 | |
| Tarsus Pharmaceuticals (TARS) | 3.8 | $41M | 1.4M | 28.98 | |
| Trillium Therapeutics Com New | 2.8 | $30M | 3.1M | 9.69 | |
| Anaptysbio Inc Common (ANAB) | 2.2 | $23M | 900k | 25.93 | |
| Alpine Immune Sciences | 2.1 | $23M | 2.6M | 9.00 | |
| Syndax Pharmaceuticals (SNDX) | 1.9 | $20M | 1.2M | 17.17 | |
| Sutro Biopharma (STRO) | 1.7 | $19M | 1.0M | 18.59 | |
| Iveric Bio | 1.5 | $16M | 2.5M | 6.31 | |
| Chinook Therapeutics | 1.4 | $16M | 1.1M | 14.12 | |
| Autolus Therapeutics Spon Ads (AUTL) | 1.4 | $15M | 2.3M | 6.64 | |
| Frazier Lifesciences Acqu Unit 12/09/2025 | 1.4 | $15M | 1.5M | 10.05 | |
| Regenxbio Inc equity us cm (RGNX) | 1.3 | $14M | 352k | 38.85 | |
| Molecular Templates | 1.0 | $11M | 1.4M | 7.82 | |
| Gritstone Oncology Ord (GRTSQ) | 0.9 | $9.4M | 1.0M | 9.13 | |
| Essa Pharma Com New (EPIX) | 0.8 | $9.0M | 317k | 28.57 | |
| Aclaris Therapeutics (ACRS) | 0.6 | $6.5M | 371k | 17.56 | |
| Epizyme | 0.6 | $6.1M | 739k | 8.31 | |
| Aptinyx | 0.5 | $5.3M | 1.9M | 2.83 | |
| Scholar Rock Hldg Corp (SRRK) | 0.4 | $4.5M | 156k | 28.90 | |
| Freeline Therapeutics Hldgs Sponsored Ads | 0.4 | $4.5M | 550k | 8.15 | |
| Allena Pharmaceuticals | 0.4 | $4.3M | 3.3M | 1.30 | |
| Bellus Health Com New | 0.4 | $4.0M | 1.3M | 3.11 | |
| Sierra Oncology Com New | 0.4 | $3.9M | 203k | 19.47 | |
| Avadel Pharmaceuticals Sponsored Adr | 0.4 | $3.9M | 578k | 6.73 | |
| Immunovant (IMVT) | 0.2 | $2.7M | 254k | 10.57 | |
| Galera Therapeutics (GRTX) | 0.2 | $2.4M | 241k | 9.83 | |
| Nabriva Therapeutics SHS | 0.1 | $575k | 426k | 1.35 |
